Children with resistant leukemia given CRISPR-edited T cells: Phase 1 study results reported

byUniversity College LondonAn artist’s depiction of a T cell. Credit: NIAIDResearchers at Great Ormond Street Hospital for Children (GOSH) and UCL Great Ormond Street Institute of Child Health (

Updated on: January 02,2024

Children with resistant leukemia given CRISPR-edited T cells: Phase 1 study results reported

byUniversity College LondonAn artist’s depiction of a T cell. Credit: NIAIDResearchers at Great Ormond Street Hospital for Children (GOSH) and UCL Great Ormond Street Institute of Child Health (

Updated on:January 02,2024

Metachronous pathology assessed in young-onset colorectal cancer survivors

The incidence rate of clinically significant metachronous colorectal pathology is 32 per 1,000 person-years after index young-onset colorectal cancer (YOCRC), according to a research letter published

Updated on: January 02,2024

Metachronous pathology assessed in young-onset colorectal cancer survivors

The incidence rate of clinically significant metachronous colorectal pathology is 32 per 1,000 person-years after index young-onset colorectal cancer (YOCRC), according to a research letter published

Updated on:January 02,2024

Study shows why a common form of immunotherapy fails, and suggests solution

by Georgetown University Medical CenterSamir N. Khleif, MD, director of The Loop Immuno-Oncology Laboratory at Georgetown Lombardi, led the research team that published new research on checkpoint

Updated on: March 01,2024

Study shows why a common form of immunotherapy fails, and suggests solution

by Georgetown University Medical CenterSamir N. Khleif, MD, director of The Loop Immuno-Oncology Laboratory at Georgetown Lombardi, led the research team that published new research on checkpoint

Updated on:March 01,2024

New biomarker strategy devised to screen for, diagnose deadly heart complication from cancer treatment

byUniversity of MichiganCredit: Unsplash/CC0 Public DomainResearchers at Michigan Medicine have devised a new biomarker-based strategy to screen for a rare and deadly complication caused by mono

Updated on: January 12,2024

New biomarker strategy devised to screen for, diagnose deadly heart complication from cancer treatment

byUniversity of MichiganCredit: Unsplash/CC0 Public DomainResearchers at Michigan Medicine have devised a new biomarker-based strategy to screen for a rare and deadly complication caused by mono

Updated on:January 12,2024

Study shows multiple beams, intervals in delivery decrease the skin-saving benefits of FLASH radiotherapy for cancer

by Katie Pence,University of CincinnatiCredit: CC0 Public DomainA published study by researchers at the University of Cincinnati Cancer Center and Cincinnati Children's Hospital Medical Cent

Updated on: January 16,2024

Study shows multiple beams, intervals in delivery decrease the skin-saving benefits of FLASH radiotherapy for cancer

by Katie Pence,University of CincinnatiCredit: CC0 Public DomainA published study by researchers at the University of Cincinnati Cancer Center and Cincinnati Children's Hospital Medical Cent

Updated on:January 16,2024

New law regulating out-of-pocket drug spending saves cancer patients more than $7,000 a year, study finds

byUniversity of MichiganCredit: Ivan Samkov from PexelsAs prescription oral chemotherapies have become a common form of cancer treatment, some patients were paying more than $10,000 a year for m

Updated on: September 28,2024

New law regulating out-of-pocket drug spending saves cancer patients more than $7,000 a year, study finds

byUniversity of MichiganCredit: Ivan Samkov from PexelsAs prescription oral chemotherapies have become a common form of cancer treatment, some patients were paying more than $10,000 a year for m

Updated on:September 28,2024

First-line ribociclib and endocrine therapy may be more effective than combined chemotherapy in aggressive breast cancer

by American Association for Cancer ResearchCredit: Pixabay/CC0 Public DomainIn patients with hormone receptor-positive, HER2-negative, advanced breast cancer—including patients with visceral cris

Updated on: February 01,2024

First-line ribociclib and endocrine therapy may be more effective than combined chemotherapy in aggressive breast cancer

by American Association for Cancer ResearchCredit: Pixabay/CC0 Public DomainIn patients with hormone receptor-positive, HER2-negative, advanced breast cancer—including patients with visceral cris

Updated on:February 01,2024

In situ, invasive melanoma diagnoses decreased in 2020

by Elana GotkineDuring 2020, there were decreases seen for in situ and invasive melanoma diagnoses, according to a research letter published online Sept. 6 inJAMA Dermatology.Daniel Y. Kim, from

Updated on: January 29,2024

In situ, invasive melanoma diagnoses decreased in 2020

by Elana GotkineDuring 2020, there were decreases seen for in situ and invasive melanoma diagnoses, according to a research letter published online Sept. 6 inJAMA Dermatology.Daniel Y. Kim, from

Updated on:January 29,2024

Researchers find genetic pathways to individualized treatment for advanced prostate cancer

by Mayo ClinicCredit: Mayo ClinicResearchers at Mayo Clinic Center for Individualized Medicine have uncovered genetic clues to why tumors resist a specific therapy used for treating advanced pros

Updated on: June 15,2024

Researchers find genetic pathways to individualized treatment for advanced prostate cancer

by Mayo ClinicCredit: Mayo ClinicResearchers at Mayo Clinic Center for Individualized Medicine have uncovered genetic clues to why tumors resist a specific therapy used for treating advanced pros

Updated on:June 15,2024

New study brings personalized immunotherapy prescriptions a step closer

byUniversity of BathCredit: Unsplash/CC0 Public DomainIn a step likely to advance personalized cancer treatment, scientists have—for the first time—shown in patients that levels of biomarkers ar

Updated on: January 13,2024

New study brings personalized immunotherapy prescriptions a step closer

byUniversity of BathCredit: Unsplash/CC0 Public DomainIn a step likely to advance personalized cancer treatment, scientists have—for the first time—shown in patients that levels of biomarkers ar

Updated on:January 13,2024

Scrapping England's cancer plan is 'a catastrophic decision that will cost lives' warn experts

byBritish Medical JournalCredit: Pixabay/CC0 Public DomainThe UK government's proposal to roll England's long term plan for cancer into one strategy covering all major conditions, such a

Updated on: January 22,2024

Scrapping England's cancer plan is 'a catastrophic decision that will cost lives' warn experts

byBritish Medical JournalCredit: Pixabay/CC0 Public DomainThe UK government's proposal to roll England's long term plan for cancer into one strategy covering all major conditions, such a

Updated on:January 22,2024

How oncologists can ethically navigate the 'Right-To-Try' drug law

by Perelman School of Medicine at the University of PennsylvaniaCredit: CC0 Public DomainThe 2018 federal Right to Try Act allows patients with a life-threatening illness to be treated with drugs

Updated on: April 07,2024

How oncologists can ethically navigate the 'Right-To-Try' drug law

by Perelman School of Medicine at the University of PennsylvaniaCredit: CC0 Public DomainThe 2018 federal Right to Try Act allows patients with a life-threatening illness to be treated with drugs

Updated on:April 07,2024